| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $60.1M | — | +83.8% |
| Cost of Revenue | $7.2M | — | +96.2% |
| R&D Expense | $41.7M | — | +12.9% |
| SG&A Expense | $63.6M | — | +62.7% |
| Operating Income | -$52.4M | — | -11.4% |
| Pre-tax Income | -$55.1M | — | -11.5% |
| Income Tax | $545K | — | +581.3% |
| Net Income | -$55.6M | — | -12.4% |
| EPS (Basic) | -$0.83 | — | -2.5% |
| EPS (Diluted) | -$0.83 | — | -2.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $62.1M | +14.4% | -41.4% |
| Short-term Investments | $278.5M | -16.8% | +33.6% |
| Accounts Receivable | $34.2M | +31.1% | +91.8% |
| Inventory | $28.7M | +11.3% | +48.3% |
| Current Assets | $430.1M | -7.9% | +16.5% |
| Total Assets | $442.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$44.2M | — | -9.5% |
| Investing Cash Flow | $57.1M | — | +129.9% |
| Financing Cash Flow | -$5.4M | — | -116.6% |
| +14.4% |
| Current Liabilities | $103.2M | -2.6% | -7.7% |
| Long-term Debt | $98.3M | -2.5% | -8.9% |
| Total Liabilities | $204.7M | -2.6% | -8.5% |
| Stockholders' Equity | $122.9M | -11.6% | +548.7% |